Integra LifeSciences Corporation

IART | NASDAQ

$15.97

+$0.38 (+2.44%)

Sep 22, 2026, 10:49 AM ET · Market open

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Revenue	1.64B	1.61B	1.54B	1.56B	1.54B	1.37B
Cost of Revenue	790.01M	728.47M	656.84M	587.36M	597.81M	520.83M
Gross Profit	845.23M	882.06M	884.74M	970.31M	944.64M	851.03M
Operating Income	68.32M	28.41M	111.53M	238.92M	197.23M	151.37M
Interest Income	18.47M	20.04M	17.2M	11.92M	6.74M	9.3M
Pretax Income	-563.5M	-18.24M	81.07M	213.89M	214.68M	93.52M
Net Income	-516.47M	-6.94M	67.74M	180.55M	169.08M	133.89M
Selling & General & Admin	699.7M	716.98M	656.64M	616.32M	637.45M	594.53M
Research & Development	98.97M	115.38M	104.19M	101.19M	93.05M	77.38M
Other Expenses	-21.76M	21.29M	12.38M	13.88M	16.91M	27.76M
Operating Expenses	776.92M	853.65M	773.21M	731.39M	747.41M	699.66M
Interest Expense	86.26M	70.63M	51.38M	49.59M	50.4M	71.58M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	1.57B	1.58B	1.43B	1.32B	1.35B	1.22B
Income Tax Expense	-47.03M	-11.29M	13.33M	33.34M	45.6M	-40.37M
Shares Outstanding (Basic)	76.75M	77.01M	78.17M	83M	84.7M	84.65M
Shares Outstanding (Diluted)	76.75M	77.01M	80.34M	83.52M	85.49M	85.23M
EPS (Basic)	-6.73	-0.09	0.87	2.18	2	1.58
EPS (Diluted)	-6.73	-0.09	0.84	2.16	1.98	1.57
EBITDA	-326.2M	193.29M	255.96M	384.6M	366.33M	267.93M
EBIT	-477.25M	52.4M	132.45M	263.49M	242.66M	148.95M
Depreciation & Amortization	151.05M	140.5M	123.51M	121.12M	123.67M	118.99M